The distinguished Dr. Donald Abrams, cancer specialist and

New Post Public Reply Private Reply Replies (3) Message Board
bellsandwhistles bellsandwhistles #14413
The distinguished Dr. Donald Abrams, cancer specialist and integrative medicine specialist, is chief of Hematology and Oncology at San Francisco General Hospital. Here is how the good doctor fits into the Simpson Oil / Dharmanol story.

Background:

Donald Abrams, M.D. Cancer and integrative medicine specialist.

"Dr. Donald I. Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. Abrams provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative therapies including mind-body treatments, botanical therapies, medical use of marijuana and traditional Chinese medicine herbal therapies.

In addition to his role at the Osher center, he is chief of Hematology and Oncology at San Francisco General Hospital. Abrams, who has been in the forefront of HIV/AIDS research and treatment, stepped down from the HIV Clinic at San Francisco General Hospital in August 2006 to devote more time to integrative medicine and oncology. He is an executive committee member of the UCSF Helen Diller Family Comprehensive Cancer Center and is co-chair of of the center's program in Symptom Management, Palliative Care and Survivorship. In 2004, he completed an associate fellowship in integrative medicine at the University of Arizona."
http://www.ucsfhealth.org/donald.abrams

D. Hoye writes:

"As the anecdotal evidence built up in the medicinal cannabis community, top “legitimate” medical researchers in the field took notice.

An example is a group of cannabis activists in Santa Cruz, California who have been supplying Simpson oil to cancer patients. In this convincing study on multiple types of cancer, 25 stage four patients were directed to the group by a San Francisco oncologist, who has chosen to remain anonymous. The treatments were observed and monitored by Dr. Abrams, who could not participate officially because the cannabis oil came from the world of medical marijuana instead of the official government marijuana farm in Mississippi.

Dr. Abrams was amazed to see that 24 of the 25 stage four cancer cases went into remission. Statistically, this is unheard of in the world of medicine. In actuality, it is common among those who have treated their cancer with cannabis according to Simpson’s instructions on the internet.

Dr. Abrams increased his efforts to obtain some official oil to do the placebo-controlled double-blind experiments. The scientist running the government marijuana farm says he has a vial of oil just sitting there waiting for the okay to send it to Dr. Abrams. Has it happened? No. Is it expected soon? Who knows?"

"In light of all the evidence, several small research laboratories have sprung up in cannabis-friendly states operating under the auspices of state laws. Unfettered by federal regulations since August 29, 2013 when the federal government announced they would respect state laws on these matters, these independent laboratories are working on all aspects of cannabis medicine, from pure research into the inner workings of the molecules to development of delivery systems which will allow medicinalization of the raw herb.

One such independent laboratory is Berkeley Bio-Organic Research Laboratories, LLC, located in the San Francisco Bay Area. Operated by two long-time advocates of cannabis science and cannabis medicine, Berkeley Bio’s main concentration is the medicinalization of cannabinoid therapy, especially for the treatment of cancer."

http://iequitycancerfoundation.org/index.php/...omed?id=88

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Admetec Shines Bright with New High-Magnification Headlights

Updated Category News Views 112

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...

Continue Reading
Duke Energy's $500K Push Against South Carolina Hunger

Updated Category News Views 133

A Battle Cry Against Hunger Look, there’s no shortage of firms tossing around cash as PR stunts. But Duke Energy’s latest campaign to tackle hunger in South Carolina right at the root is one effort that seems to echo with a real bang. Coming at us with more than $500,000 in support for nearly 70 organizations across the state, they’re not just talking the talk. This...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 58

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 71

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 62

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Wheels Up Expands Fleet with New Phenom 300E Jets

Updated Category News Views 70

Wheels Up's New Horizons with Phenom 300E Jets Wheels Up Experience Inc. (NYSE: UP) just dropped a bombshell with their plan to purchase six spanking new Phenom 300E jets from Embraer (NYSE: EMBJ). This ain't just another lease agreement; this is their first-ever direct buy from Embraer, and it's set to add some serious flair to their fleet. Setting the Stage for Growth...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 53

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Borussia Dortmund's Q1 2026/2027 Earnings Slip Amid Challenges

Updated Category News Views 49

An Uneven Start to Borussia Dortmund's Financial Year Every finance year kickoff has its tales, and Borussia Dortmund's start for 2026/2027 is no different. The embattled team has been juggling a mixed bag of financial outcomes, darting through initial challenges with a revenue that hovers slightly above the previous year's mark. Revenue crept up to EUR 107.4 million,...

Continue Reading
Drone Composites Market Set for Major Growth by 2031

Updated Category News Views 208

Drone Composites: A Market Poised for Surge Strap in, folks! The drone composites market is gearing up for a wild ride, projected to nearly double from $7.06 billion in 2026 to a whopping $13.59 billion by 2031. That's a solid 14% compound annual growth rate (CAGR) for those keeping score at home. With those numbers, it's no wonder market players are strategizing hard to...

Continue Reading
NIH Seeks AI Solutions for Kidney Disease Breakthroughs

Updated Category News Views 128

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Continue Reading

Top 5 Most Recently Viewed Articles

Christine Russell's Stock Options Move at eGain: What You Should Know

Updated Category News Views 186

Christine Russell's Stock Option Exercise at eGain In a recent filing with the SEC, it was disclosed that Christine Russell, a Board Member at eGain, executed an options exercise that ended up realizing no monetary gain due to the exercise price being set at $0.0. This move raised eyebrows among investors as it was worth 0 shares of the company, painted against eGain's...

Continue Reading
Crown Castle's Q3 2024 Earnings: Growth and Strategic Initiatives

Updated Category News Views 103

Performance Highlights from Crown Castle's Q3 2024 Crown Castle International Corp. (NYSE: CCI) delivered a commendable performance in its third quarter of 2024, showcasing its resilience in the competitive telecommunications sector. The company maintained its full-year outlook for adjusted EBITDA and AFFO while anticipating consolidated organic revenue growth of...

Continue Reading
Alliance Pharma: Significant Recent Activity in Trading

Updated Category News Views 185

Overview of Recent Trading Activity at Alliance Pharma In the landscape of finance, keeping track of significant trading activities is paramount for stakeholders. This is especially true for companies like Alliance Pharma plc, known for their strategic initiatives that directly impact the market. Recently, important disclosures related to trading have captured the...

Continue Reading
Wall Street Surges as Major Corporations Drive Optimism

Updated Category News Views 145

Wall Street's Historic Rally Wall Street has witnessed an impressive rally lately, with significant benchmarks like the S&P 500 and the Nasdaq 100 soaring to all-time highs. This upward momentum is largely attributed to robust corporate earnings, positive economic indicators, and a growing enthusiasm for technology, particularly driven by advancements in artificial...

Continue Reading
AKVA Group ASA: Insights Await as Q3 2025 Results Unveiled

Updated Category News Views 197

Invitation to Q3 2025 Financial Results Presentation AKVA group ASA is excited to extend an invitation for the presentation of its Q3 2025 financial results. This is an excellent opportunity for investors, stakeholders, and anyone interested in understanding the company's performance during this period. Presentation Details The presentation is scheduled for Friday,...

Continue Reading